skip to main content

Opens in a new window Opens an external site Opens an external site in a new tab

Network publishes its Phase 1 Innovation Report!
This live document captures the Network’s growing impact—highlighting the milestones achieved, the lessons learned and the foundation we’ve built for the next phase of our journey!

Other sites in our network

The Terry Fox Research Institute
Digital Health and discovery Platform (DHDP)
The Terry Fox Foundation

When autocomplete results are available use up and down arrows to review and enter to select.

Marathon of Hope Cancer Centres Network
The Terry Fox Research Institute
Digital Health and Discovery Platform (DHDP)
The Terry Fox Foundation

EN
FR

Watch us on YouTube
Join the Conversation on Bluesky
Join us on LinkedIn

About Us
Our Network
Our Research
News & Impact
Researcher Hub
Patient Hub
- Pan-Canadian Patient Forum
Innovation Report

Trevor Pugh

ResearcherProject LeaderWorking Group ChairWorking Group Member

University Health Network - Princess Margaret Cancer Centre
Ontario Institute for Cancer Research

Locations

Ontario

Working Groups

Technology Working Group Chair
Biospecimens Working Group Chair

Steering Committee Member
Immune Profiling Subgroup Member
Hematology Biospecimens Subgroup Member
Scientific Questions Working Group Member

Home > Our Network > Trevor Pugh

Projects

CfDNA in Hereditary and High-Risk Malignancies (CHARM)
Immune Resistance Interrogation Study (IRIS)
Investigator-initiated Phase II Study of Pembrolizumab Immunological Response Evaluation (INSPIRE)
Marathon of Hope Cancer Centres Network Study for Ontario/Canadian Atezolizumab Precision Targeting for Immunotherapy Intervention (MOHCCN-O/CAPTIV-8)
Non-Invasive Monitoring of Liver Cancer Recurrence Following Surgery and/or Transplant Using Circulating Tumour DNA Sequencing (ctDNA in HCC)
The Integrated Molecular Profiling of Multiple Myeloma and Related Plasma Cell Dyscrasias using Blood and Bone Marrow Samples (IMMAGINE)
Cell-free whole genome and epigenome sequencing to detect and classify cancers from plasma circulating DNA
Improving patient matching to therapy via streamlining clinical trial eligibility criteria to guide precision oncology (PMATCH)
New software created by Marathon of Hope Cancer Centres Network researchers will connect cancer patients to clinical trials across the country
Early cancer detection using circulating tumour DNA enabled by whole genome sequencing of primary solid tumours
The Canadian Cholangiocarcinoma Collaborative (C3) Whole Genome Transcriptome Sequencing Project
An integrated approach to characterize high-risk disease in myeloma at Princess Margaret

Related News

News Item

MOHCCN Researchers Share Their Clinical Trial Projects With the Network
On Wednesday, February 4, MOHCCN members conducting Network-funded projects in the clinical trials space presented their ongoing work in precision oncology to Network members as part of the MOHCCN sem...
Research Highlight

Precision medicine should be first-line treatment for metastatic pancreatic cancer, study finds
A new clinical trial comparing the efficacy of two treatments commonly used on patients with metastatic pancreatic cancer has shed new light on the importance of using genomic sequencing to inform car...

Regional Consortia
Ontario Cancer Consortium

Ontario

The Ontario Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine for cance...
Read more

675 West 10th Avenue, 14th Floor, Vancouver, BC, Canada V5Z 1L3

P:604.675.8222|E:moh@tfri.ca

About Us
Our Network
Our Research
News & Impact
Researcher Hub
Patient Hub
Innovation Report

Watch us on YouTube
Join the Conversation on Bluesky
Join us on LinkedIn

Supported By

Terry Fox Foundation

© 2024 The Marathon of Hope Cancer Centres Network. All rights reserved | Privacy and Terms

Designed and developed by Cubicle Fugitive